These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20639252)

  • 1. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
    Whynes DK; Mangham CM; Balfour TW; Scholefield JH
    Gut; 2010 Aug; 59(8):1088-93. PubMed ID: 20639252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
    Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
    Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.
    Mapp TJ; Hardcastle JD; Moss SM; Robinson MH
    Br J Surg; 1999 Oct; 86(10):1286-91. PubMed ID: 10540135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.
    Robinson MH; Rodrigues VC; Hardcastle JD; Chamberlain JO; Mangham CM; Moss SM
    J Med Screen; 2000; 7(2):97-8. PubMed ID: 11002450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 14. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
    Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ
    Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does yearly fecal exam for occult blood lower colorectal cancer mortality?].
    Gerbes L; Jüngst D; Köbberling J
    Z Gastroenterol; 1994 Oct; 32(10):603-6. PubMed ID: 7716998
    [No Abstract]   [Full Text] [Related]  

  • 17. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
    Oliphant R; McLoone P; Morrison D
    Gut; 2011 Aug; 60(8):1163-4. PubMed ID: 21193450
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term mortality after screening for colorectal cancer.
    Shaukat A; Mongin SJ; Geisser MS; Lederle FA; Bond JH; Mandel JS; Church TR
    N Engl J Med; 2013 Sep; 369(12):1106-14. PubMed ID: 24047060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.